Listed

REGENXBIO Inc.

RGNXNasdaqCIK 1590877HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$108.0m, Q2 FY2026
Operating income$29.3m, Q2 FY2026
Net income$22.7m, Q2 FY2026
REGENXBIO Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m28.9Revenue, Q3 FY2023, three months to 2023-09-30$28.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure22.2Revenue, Q4 FY2023, three months to 2023-12-31$22.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure15.6Revenue, Q1 FY2024, three months to 2024-03-31$15.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure22.3Revenue, Q2 FY2024, three months to 2024-06-30$22.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure24.2Revenue, Q3 FY2024, three months to 2024-09-30$24.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure21.2Revenue, Q4 FY2024, three months to 2024-12-31$21.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure89.0Revenue, Q1 FY2025, three months to 2025-03-31$89.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure21.4Revenue, Q2 FY2025, three months to 2025-06-30$21.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure29.7Revenue, Q3 FY2025, three months to 2025-09-30$29.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure30.3Revenue, Q4 FY2025, three months to 2025-12-31$30.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure6.4Revenue, Q1 FY2026, three months to 2026-03-31$6.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure108Revenue, Q2 FY2026, three months to 2026-06-30$108.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Cost of revenue$m12.4Cost of revenue, Q3 FY2023, three months to 2023-09-30$12.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure11.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$11.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure4.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$4.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure10.6Cost of revenue, Q2 FY2024, three months to 2024-06-30$10.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure12.4Cost of revenue, Q3 FY2024, three months to 2024-09-30$12.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure6.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$6.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m58.2Research and development, Q3 FY2023, three months to 2023-09-30$58.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure55.7Research and development, Q4 FY2023, three months to 2023-12-31$55.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure54.8Research and development, Q1 FY2024, three months to 2024-03-31$54.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure48.9Research and development, Q2 FY2024, three months to 2024-06-30$48.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure54.4Research and development, Q3 FY2024, three months to 2024-09-30$54.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure50.4Research and development, Q4 FY2024, three months to 2024-12-31$50.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure53.1Research and development, Q1 FY2025, three months to 2025-03-31$53.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure59.5Research and development, Q2 FY2025, three months to 2025-06-30$59.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure56.1Research and development, Q3 FY2025, three months to 2025-09-30$56.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure59.6Research and development, Q4 FY2025, three months to 2025-12-31$59.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure57.3Research and development, Q1 FY2026, three months to 2026-03-31$57.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure56.1Research and development, Q2 FY2026, three months to 2026-06-30$56.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Operating income$m(65.0)Operating income, Q3 FY2023, three months to 2023-09-30−$65.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure(63.9)Operating income, Q4 FY2023, three months to 2023-12-31−$63.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure(63.9)Operating income, Q1 FY2024, three months to 2024-03-31−$63.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure(56.0)Operating income, Q2 FY2024, three months to 2024-06-30−$56.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure(62.1)Operating income, Q3 FY2024, three months to 2024-09-30−$62.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure(51.4)Operating income, Q4 FY2024, three months to 2024-12-31−$51.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure12.1Operating income, Q1 FY2025, three months to 2025-03-31$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure(63.3)Operating income, Q2 FY2025, three months to 2025-06-30−$63.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure(52.4)Operating income, Q3 FY2025, three months to 2025-09-30−$52.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure(57.6)Operating income, Q4 FY2025, three months to 2025-12-31−$57.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure(83.4)Operating income, Q1 FY2026, three months to 2026-03-31−$83.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure29.3Operating income, Q2 FY2026, three months to 2026-06-30$29.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Interest expense$m1.6Interest expense, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0000950170-23-061144.Report this figure1.4Interest expense, Q4 FY2023, three months to 2023-12-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-27, accession 0000950170-24-021161. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure0.4Interest expense, Q2 FY2024, three months to 2024-06-30$449.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure0.8Interest expense, Q3 FY2024, three months to 2024-09-30$820.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure9.4Interest expense, Q4 FY2024, three months to 2024-12-31$9.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure8.6Interest expense, Q1 FY2025, three months to 2025-03-31$8.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure11.0Interest expense, Q2 FY2025, three months to 2025-06-30$11.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure13.2Interest expense, Q3 FY2025, three months to 2025-09-30$13.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure12.3Interest expense, Q4 FY2025, three months to 2025-12-31$12.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure8.7Interest expense, Q1 FY2026, three months to 2026-03-31$8.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure7.8Interest expense, Q2 FY2026, three months to 2026-06-30$7.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(61.9)Net income, Q3 FY2023, three months to 2023-09-30−$61.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure(62.9)Net income, Q4 FY2023, three months to 2023-12-31−$62.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure(63.3)Net income, Q1 FY2024, three months to 2024-03-31−$63.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure(53.0)Net income, Q2 FY2024, three months to 2024-06-30−$53.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure(59.6)Net income, Q3 FY2024, three months to 2024-09-30−$59.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure(51.2)Net income, Q4 FY2024, three months to 2024-12-31−$51.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure6.1Net income, Q1 FY2025, three months to 2025-03-31$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure(70.9)Net income, Q2 FY2025, three months to 2025-06-30−$70.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure(61.9)Net income, Q3 FY2025, three months to 2025-09-30−$61.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure(67.1)Net income, Q4 FY2025, three months to 2025-12-31−$67.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure(90.1)Net income, Q1 FY2026, three months to 2026-03-31−$90.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure22.7Net income, Q2 FY2026, three months to 2026-06-30$22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Diluted EPS$ per share(1.41)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figurenot reported(1.38)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure(1.05)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure(1.17)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figurenot reported0.12Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure(1.38)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure(1.20)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figurenot reported(1.72)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure0.43Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Basic EPS$ per share(1.41)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figurenot reported(1.38)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure(1.05)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure(1.17)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figurenot reported0.12Basic EPS, Q1 FY2025, three months to 2025-03-31$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure(1.38)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure(1.20)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figurenot reported(1.72)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure0.43Basic EPS, Q2 FY2026, three months to 2026-06-30$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure

Balance sheet

Cash and equivalents$36.5m, Q2 FY2026
Shareholders' equity$71.8m, Q2 FY2026
REGENXBIO Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m53.0Cash and equivalents, Q3 FY2023, at 2023-09-30$53.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure34.5Cash and equivalents, FY2023, at 2023-12-31$34.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0000950170-25-038770.Report this figure113Cash and equivalents, Q1 FY2024, at 2024-03-31$113.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure57.8Cash and equivalents, Q2 FY2024, at 2024-06-30$57.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure56.6Cash and equivalents, Q3 FY2024, at 2024-09-30$56.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure57.5Cash and equivalents, FY2024, at 2024-12-31$57.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-094013.Report this figure130Cash and equivalents, Q1 FY2025, at 2025-03-31$130.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure79.6Cash and equivalents, Q2 FY2025, at 2025-06-30$79.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure58.8Cash and equivalents, Q3 FY2025, at 2025-09-30$58.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure34.5Cash and equivalents, FY2025, at 2025-12-31$34.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure15.2Cash and equivalents, Q1 FY2026, at 2026-03-31$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure36.5Cash and equivalents, Q2 FY2026, at 2026-06-30$36.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Current assets$m366Current assets, Q3 FY2023, at 2023-09-30$365.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061144.Report this figure335Current assets, FY2023, at 2023-12-31$335.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038770.Report this figure395Current assets, Q1 FY2024, at 2024-03-31$395.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure347Current assets, Q2 FY2024, at 2024-06-30$346.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure313Current assets, Q3 FY2024, at 2024-09-30$313.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure278Current assets, FY2024, at 2024-12-31$278.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-094013.Report this figure313Current assets, Q1 FY2025, at 2025-03-31$313.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure374Current assets, Q2 FY2025, at 2025-06-30$373.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure332Current assets, Q3 FY2025, at 2025-09-30$332.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure281Current assets, FY2025, at 2025-12-31$281.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure187Current assets, Q1 FY2026, at 2026-03-31$186.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure236Current assets, Q2 FY2026, at 2026-06-30$236.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Total assets$m634Total assets, Q3 FY2023, at 2023-09-30$633.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061144.Report this figure574Total assets, FY2023, at 2023-12-31$574.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038770.Report this figure629Total assets, Q1 FY2024, at 2024-03-31$629.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure569Total assets, Q2 FY2024, at 2024-06-30$569.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure519Total assets, Q3 FY2024, at 2024-09-30$519.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure466Total assets, FY2024, at 2024-12-31$466.0m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-094013.Report this figure491Total assets, Q1 FY2025, at 2025-03-31$490.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure581Total assets, Q2 FY2025, at 2025-06-30$581.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure525Total assets, Q3 FY2025, at 2025-09-30$525.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure453Total assets, FY2025, at 2025-12-31$453.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure342Total assets, Q1 FY2026, at 2026-03-31$341.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure387Total assets, Q2 FY2026, at 2026-06-30$386.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Current liabilities$m127Current liabilities, Q3 FY2023, at 2023-09-30$127.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061144.Report this figure130Current liabilities, FY2023, at 2023-12-31$130.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038770.Report this figure110Current liabilities, Q1 FY2024, at 2024-03-31$110.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure98.3Current liabilities, Q2 FY2024, at 2024-06-30$98.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure103Current liabilities, Q3 FY2024, at 2024-09-30$102.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure103Current liabilities, FY2024, at 2024-12-31$103.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-094013.Report this figure107Current liabilities, Q1 FY2025, at 2025-03-31$106.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure120Current liabilities, Q2 FY2025, at 2025-06-30$119.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure125Current liabilities, Q3 FY2025, at 2025-09-30$124.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure118Current liabilities, FY2025, at 2025-12-31$118.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure71.1Current liabilities, Q1 FY2026, at 2026-03-31$71.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure82.6Current liabilities, Q2 FY2026, at 2026-06-30$82.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Total liabilities$m271Total liabilities, Q3 FY2023, at 2023-09-30$270.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061144.Report this figure262Total liabilities, FY2023, at 2023-12-31$262.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0000950170-25-038770.Report this figure239Total liabilities, Q1 FY2024, at 2024-03-31$238.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure221Total liabilities, Q2 FY2024, at 2024-06-30$221.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure218Total liabilities, Q3 FY2024, at 2024-09-30$217.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure206Total liabilities, FY2024, at 2024-12-31$206.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-094013.Report this figure217Total liabilities, Q1 FY2025, at 2025-03-31$216.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure367Total liabilities, Q2 FY2025, at 2025-06-30$367.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure364Total liabilities, Q3 FY2025, at 2025-09-30$363.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure350Total liabilities, FY2025, at 2025-12-31$350.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure321Total liabilities, Q1 FY2026, at 2026-03-31$320.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure315Total liabilities, Q2 FY2026, at 2026-06-30$314.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure
Shareholders' equity$m363Shareholders' equity, Q3 FY2023, at 2023-09-30$363.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure312Shareholders' equity, FY2023, at 2023-12-31$311.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-094013.Report this figure391Shareholders' equity, Q1 FY2024, at 2024-03-31$390.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure348Shareholders' equity, Q2 FY2024, at 2024-06-30$348.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure301Shareholders' equity, Q3 FY2024, at 2024-09-30$301.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure260Shareholders' equity, FY2024, at 2024-12-31$259.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure274Shareholders' equity, Q1 FY2025, at 2025-03-31$274.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure214Shareholders' equity, Q2 FY2025, at 2025-06-30$213.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure161Shareholders' equity, Q3 FY2025, at 2025-09-30$161.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure103Shareholders' equity, FY2025, at 2025-12-31$102.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure21.1Shareholders' equity, Q1 FY2026, at 2026-03-31$21.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure71.8Shareholders' equity, Q2 FY2026, at 2026-06-30$71.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure

Cash flow

Operating cash flow−$62.2m, Q2 FY2026
Capital expenditure$760.0k, Q2 FY2026
REGENXBIO Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(49.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$49.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122330. Derived: 9-month figure less the 6-month figure.Report this figure(40.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$40.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure(55.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$55.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure(45.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$45.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001193125-25-174953. Derived: 6-month figure less the 3-month figure.Report this figure(40.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$40.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268095. Derived: 9-month figure less the 6-month figure.Report this figure(31.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$31.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure33.6Operating cash flow, Q1 FY2025, three months to 2025-03-31$33.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure(49.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$49.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336725. Derived: 6-month figure less the 3-month figure.Report this figure(56.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$56.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268095. Derived: 9-month figure less the 6-month figure.Report this figure(52.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$52.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure(76.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$76.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure(62.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$62.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336725. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.4Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122330. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0000950170-25-038770. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2024, three months to 2024-03-31$557.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$474.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001193125-25-174953. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$326.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268095. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure0.4Capital expenditure, Q2 FY2025, three months to 2025-06-30$391.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336725. Derived: 6-month figure less the 3-month figure.Report this figure0.5Capital expenditure, Q3 FY2025, three months to 2025-09-30$491.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268095. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2025, three months to 2025-12-31$508.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-094013. Derived: 12-month figure less the 9-month figure.Report this figure1.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure0.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$760.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-336725. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)53.02m, Q2 FY2026
REGENXBIO Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3043,251 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061144.Report this figure43.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3143,451,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-055691.Report this figure43.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3043,531,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0000950170-24-089320.Report this figure43.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3043,945,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122330.Report this figure45.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3145,733,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0000950170-25-069237.Report this figure50.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3050,601,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001193125-25-174953.Report this figure50.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3050,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure51.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3151,434,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure51.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3051,483,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure51.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3051,689,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268095.Report this figure52.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3152,428,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-222804.Report this figure53.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3053,016,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure

Shares outstanding: 66.01mShares outstanding, period not labelled, at 2026-07-3166,013,192 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336725.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. Listed shows no prices and gives no investment advice.